Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline
- PMID: 32663106
- PMCID: PMC7365361
- DOI: 10.1164/rccm.202005-1982ST
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline
Abstract
Background: Current tobacco treatment guidelines have established the efficacy of available interventions, but they do not provide detailed guidance for common implementation questions frequently faced in the clinic. An evidence-based guideline was created that addresses several pharmacotherapy-initiation questions that routinely confront treatment teams.Methods: Individuals with diverse expertise related to smoking cessation were empaneled to prioritize questions and outcomes important to clinicians. An evidence-synthesis team conducted systematic reviews, which informed recommendations to answer the questions. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach was used to rate the certainty in the estimated effects and the strength of recommendations.Results: The guideline panel formulated five strong recommendations and two conditional recommendations regarding pharmacotherapy choices. Strong recommendations include using varenicline rather than a nicotine patch, using varenicline rather than bupropion, using varenicline rather than a nicotine patch in adults with a comorbid psychiatric condition, initiating varenicline in adults even if they are unready to quit, and using controller therapy for an extended treatment duration greater than 12 weeks. Conditional recommendations include combining a nicotine patch with varenicline rather than using varenicline alone and using varenicline rather than electronic cigarettes.Conclusions: Seven recommendations are provided, which represent simple practice changes that are likely to increase the effectiveness of tobacco-dependence pharmacotherapy.
Keywords: dependence; pharmacotherapy; smoking; tobacco; treatment.
Figures
Similar articles
-
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.Arch Bronconeumol. 2023 Oct;59(10):651-661. doi: 10.1016/j.arbres.2023.07.024. Epub 2023 Jul 28. Arch Bronconeumol. 2023. PMID: 37567792 English, Spanish.
-
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2. Cochrane Database Syst Rev. 2023. PMID: 37696529 Free PMC article. Review.
-
Treatment of Tobacco Smoking: A Review.JAMA. 2022 Feb 8;327(6):566-577. doi: 10.1001/jama.2022.0395. JAMA. 2022. PMID: 35133411 Review.
-
Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2021 Jan 19;325(3):280-298. doi: 10.1001/jama.2020.23541. JAMA. 2021. PMID: 33464342
-
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.High Blood Press Cardiovasc Prev. 2020 Oct;27(5):349-362. doi: 10.1007/s40292-020-00396-9. Epub 2020 Jun 23. High Blood Press Cardiovasc Prev. 2020. PMID: 32578165 Free PMC article. Review.
Cited by
-
Lung Cancer in Missouri.Mo Med. 2024 Sep-Oct;121(5):368-372. Mo Med. 2024. PMID: 39421481 Free PMC article. Review.
-
Effectiveness of smoking cessation interventions among adults: an overview of systematic reviews.Syst Rev. 2024 Jul 12;13(1):179. doi: 10.1186/s13643-024-02570-9. Syst Rev. 2024. PMID: 38997788 Free PMC article.
-
Real-World Treatment Adherence to Smoking Cessation Medications and Association with Treatment Outcome - 27 Centers, China, 2017-2022.China CDC Wkly. 2024 May 31;6(22):522-529. doi: 10.46234/ccdcw2024.100. China CDC Wkly. 2024. PMID: 38855569 Free PMC article.
-
Economic Evaluation of Enhanced vs Standard Varenicline Treatment for Tobacco Cessation.JAMA Netw Open. 2024 Apr 1;7(4):e248727. doi: 10.1001/jamanetworkopen.2024.8727. JAMA Netw Open. 2024. PMID: 38683609 Free PMC article. Clinical Trial.
-
Efficacy of bupropion and varenicline genetic markers in choosing pharmacological treatment for smoking cessation, and implications for combining drugs: A randomized controlled trial - GENTSMOKING.Tob Induc Dis. 2024 Apr 16;22. doi: 10.18332/tid/186072. eCollection 2024. Tob Induc Dis. 2024. PMID: 38628555 Free PMC article.
References
-
- U.S. Department of Health and Human Services. Atlanta, GA: U.S. Department of Health and Human Services; Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 1988. The health consequences of smoking: nicotine addiction. A report of the Surgeon General. [accessed 2019 Aug 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK44695/
-
- Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Smoking Cessation Guideline PanelClinical practice guideline 18: smoking cessation.Rockville, MD: U.S. Department of Health and Human Services, USPHS, Agency for Health Care Policy and Research; 1996
-
- Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, et al. Tobacco Use and Dependence Guideline PanelTreating tobacco use and dependence: 2008 update: clinical practice guideline.Rockville, MD: USPHS, U.S. Department of Health and Human Services; 2008
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
